Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Infection and Chemotherapy
Published in: Journal of Infection and Chemotherapy 6/2006

01-12-2006 | ORIGINAL ARTICLE

Alterations of pbp1a, pbp2b, and pbp2x in Streptococcus pneumoniae isolates from children with otolaryngological infectious disease in the Sapporo district of Japan

Authors: Atsushi Harimaya, Shin-ichi Yokota, Kiyoshi Sato, Jun-ichi Koizumi, Norikazu Yamazaki, Tetsuo Himi, Nobuhiro Fujii

Published in: Journal of Infection and Chemotherapy | Issue 6/2006

Login to get access
Metadata
Title
Alterations of pbp1a, pbp2b, and pbp2x in Streptococcus pneumoniae isolates from children with otolaryngological infectious disease in the Sapporo district of Japan
Authors
Atsushi Harimaya
Shin-ichi Yokota
Kiyoshi Sato
Jun-ichi Koizumi
Norikazu Yamazaki
Tetsuo Himi
Nobuhiro Fujii
Publication date
01-12-2006
Publisher
Springer-Verlag
Published in
Journal of Infection and Chemotherapy / Issue 6/2006
Print ISSN: 1341-321X
Electronic ISSN: 1437-7780
DOI
https://doi.org/10.1007/s10156-006-0473-8

Other articles of this Issue 6/2006

Journal of Infection and Chemotherapy 6/2006 Go to the issue

ORIGINAL ARTICLE

To reduce catheter-related bloodstream infections: Is the subclavian route better than the jugular route for central venous catheterization?

ORIGINAL ARTICLE

Etiology and clinical study of community-acquired pneumonia in 157 hospitalized children

NOTE

Ciprofloxacin therapy for typhoid fever needs reconsideration

CASE REPORT

Quinupristin/dalfopristin and voriconazole controlled Staphylococcus epidermidis pneumonia and chronic necrotizing aspergillosis in a patient with severe lung degradation consequent to multiple treatments for Hodgkin's lymphoma

ORIGINAL ARTICLE

Efficacy of intravenous itraconazole against invasive pulmonary aspergillosis in neutropenic mice

ORIGINAL ARTICLE

Clinical characteristics and outcomes of bacteremia caused by Acinetobacter species other than A. baumannii: comparison with A. baumannii bacteremia
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits